National Institute of Health - Office of Biotechnology Activities NIH Guidance on Informed Consent
For Gene Transfer Research

Previous Print this page. Sample Language Next

HOW TO PRINT

  • To print this page, use your browser's print button.
  • To print the entire document, download the PDF or click here and use your browser's print button.

SAMPLE LANGUAGE

MAIN POINTS

  • Potential participants should be given sufficient time to decide whether they want to enroll in the study.


Appendix M-III-A-3
Time for Decision Making

NIH GUIDELINES: "What is the length of time that potential participants will have to make a decision about their participation in the study?"

DISCUSSION
In order to make an informed decision concerning study participation, potential participants should be given ample time to review the consent form, to ask questions, and to discuss their decision with others as desired.

Many institutional review boards provide guidance to investigators on this issue, including recommendations that potential participants take the consent form home to discuss it with family members or primary care providers before making an enrollment decision.

Investigators and IRBs should consider the following:

  • Participants in gene transfer studies may desire or require very different amounts of time to decide whether to participate in the study.
  • Some potential participants may come to the consent process having already decided to participate - perhaps having already traveled and made plans or financial commitments. This possibility should be acknowledged in the consent process so that, when appropriate, the investigator can emphasize the significance of the information conveyed in the consent form and process.
  • Commitment to research participation is ongoing. It may be advisable to design a process for revisiting consent, reporting regularly to participants on significant developments that may affect their decision to remain in the study. Such a process may be used at intervals during participation and for long-term follow-up to reconfirm participation. It may also be required whenever new information is learned that could affect a participant's willingness to continue in the study, or that may have health implications for persons who have received the intervention.

SAMPLE LANGUAGE FOR CONSENT PROCESS

Process Sample 1

You may have already thought a lot about participating in this study. You may even have already made a decision about whether to be in the study. Even if this is true for you, it is important that we provide you with this information and talk about it before we start you in the study. Some information may be new or different. Some could even change your mind. It is always okay to change your mind about being in the study. And even if you don't change your mind, the information can help you understand the study better.

SAMPLE LANGUAGE


Home Top of Page Table of Contents Sample Language Previous Page Next Page